Skip to the lineages
Regenerative Medicine

How Do NSAIDs Affect Platelet Function Before a PRP Procedure?

Published November 16, 2026

Protocol: 6 steps in this guide
  1. Platelet COX pathway in plain language
  2. Aspirin versus ibuprofen and other NSAIDs
  3. Platelet function versus clinical outcome
  4. Evidence for withholding protocols
  5. Pain-control alternatives only under clinician review
  6. Patients who must not stop prescribed antiplatelets

Some pain relievers can make platelets less able to clump together and release their contents, and PRP depends on those same platelets. That is why PRP guidance asks about anti-inflammatory drugs before an injection. The effect differs by drug: studies find it with aspirin and nonselective NSAIDs such as ibuprofen and naproxen, but not with COX-2-selective NSAIDs, and the length of the effect varies from hours to days. Reduced platelet clumping in a laboratory test is not proof that PRP will work less well, and no one should stop aspirin or any other prescribed medication for a PRP appointment without speaking to the prescriber.

Platelet COX pathway in plain language

Platelets use an enzyme called cyclooxygenase-1 (COX-1) as part of the process that makes them clump and release their contents. A 2024 review in Cureus, A Review of Platelet-Rich Plasma Use in Patients Taking Non-steroidal Anti-inflammatory Drugs, explains that platelets release their active components “through a degranulation process, which is inhibited by certain nonsteroidal anti-inflammatory drugs (NSAIDs),” and focuses on NSAIDs that inhibit COX-1, “a key enzyme in clotting.”

NSAIDs fall into nonselective and COX-2-selective groups, and the platelet studies below treat them separately because they behaved differently.

Aspirin versus ibuprofen and other NSAIDs

A 2022 systematic review in the Orthopaedic Journal of Sports Medicine, A Systematic Review on the Effect of Common Medications on Platelet Count and Function, included 20 studies. It reported:

Medication Effect on platelet aggregation in the review
Aspirin (268 patients) Significant decrease
Nonselective NSAIDs Significant decrease
COX-2-selective NSAIDs No significant difference
Acetaminophen (13 patients) Significant decrease
Statins (73 patients) No significant decrease

None of these drugs significantly lowered the platelet count itself; the effect was on function.

The Cureus review looked at how long the effect lasts for individual drugs, based on 25 studies. It reported that naproxen inhibited platelet aggregation “lasting at least 24 hours, with possible inhibition even at 48 hours,” that ibuprofen and diclofenac inhibit aggregation “for 6-12 hours, depending on dose,” and that indomethacin studies found recovery by 24 hours. On acetaminophen, it concluded that as “a mild inhibitor of COX-1,” it “does not require deferral.”

The two reviews therefore disagree about acetaminophen: one found a significant drop in aggregation in a small group of 13 patients, the other judged it not to need deferral. That disagreement is one reason the decision belongs with the clinician, not a general rule.

Platelet function versus clinical outcome

A drop in platelet aggregation measured in a laboratory is a change in a test, not a measured change in how patients do after PRP. The 2022 review concluded that aspirin, acetaminophen and nonselective NSAIDs “should be considered for suspension before a PRP injection because of their potential to diminish the effects of the injection.” “Potential” is the operative word. The sources reviewed here do not report trials showing that patients who took these drugs had worse PRP results.

Evidence for withholding protocols

Recommendations exist, but they are not uniform:

These are recommendations for clinicians planning a procedure. They are not instructions for patients to change their own medication, and they do not establish a single washout period that applies to every drug and product.

Pain-control alternatives only under clinician review

If a clinic asks you to avoid anti-inflammatory drugs around a PRP injection, the question of what you can take for pain instead should be answered by the treating clinician, who knows your health and your other medicines. The two reviews above disagree about acetaminophen, so this article does not recommend a substitute. Pain after the injection itself is covered in how long soreness lasts after a PRP injection.

Patients who must not stop prescribed antiplatelets

Some people take aspirin or other antiplatelet or anticoagulant drugs to prevent heart attack, stroke or blood clots. The U.S. Food and Drug Administration’s page on using aspirin to lower your risk of heart attack or stroke states: “Only a health care provider can determine whether regular use of aspirin will help to prevent a heart attack or stroke in your particular case.” It adds that daily aspirin therapy should be used “only after first talking to your health care provider.”

The same logic applies in reverse: an elective PRP injection is not a reason to stop a medicine prescribed for heart or stroke prevention on your own. If a clinic suggests stopping such a drug, the decision should be made with the clinician who prescribed it, weighing the risk of stopping against any possible effect on the PRP. It may be that PRP is not the right choice while you need that medicine.

Before the appointment, give the clinic a full list of what you take, including over-the-counter pain relievers, aspirin and supplements. Other risks of the procedure are covered in what the main risks of a PRP injection are, and how PRP is prepared from your blood in how platelet-rich plasma is made from a blood sample.

Aspirin and nonselective NSAIDs can reduce platelet function for hours to days, which is why PRP guidance asks about them, but the clinical impact is unproven, deferral advice varies, and prescribed heart or stroke medication should never be stopped without the prescriber’s agreement.

Cells linked to this one

This guide leads on to

Guides that lead here

Lineage B: PRP Preparation and Procedure

What readers added

Add a remark

Your email address will not be published. Required fields are marked *